Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT06542939

Scaling Telehealth Models to Improve Co-morbid Diabetes and Hypertension in Immigrant Populations (Phase II)

Status
Enrolling By Invitation
Phase
N/A
Study type
Interventional
Enrollment
450 (estimated)
Sponsor
NYU Langone Health · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to test the effectiveness and implementation process of a culturally and contextually tailored telehealth-based community health workers (CHW) led coaching intervention for hypertension control among South Asian patients with co-morbid Diabetes Mellitus type II (DMII) and hypertension. The primary aims are to test the effectiveness of a CHW-led telehealth intervention compared to usual care, and using Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) and Consolidated Framework for Implementation Research (CFIR), examine the reach, adoption, fidelity, and maintenance of the intervention within clinical and community settings.

Conditions

Interventions

TypeNameDescription
BEHAVIORALIntegrated CHW InterventionParticipants will undergo all 5 group-based health education sessions on hypertension and diabetes management and provide culturally and linguistically tailored health information and resources. There will be two one-on-one virtual meetings, up to 9 follow-up phone calls to engage in goal-setting activities regarding changes to health behaviors, medication adherence, or other issues related to diabetes prevention as identified jointly by patient and CHW. Participants will develop with the CHW and receive a copy of their long-term and short-term Participant Action Plan. Referrals to other services available in the community (i.e. exercise classes, social services, mental health, tobacco cessation, etc.
BEHAVIORALCHW Session 1 OnlyParticipants will attend only the first group-based health education session on hypertension and diabetes management.

Timeline

Start date
2024-11-11
Primary completion
2028-02-01
Completion
2028-02-01
First posted
2024-08-07
Last updated
2025-11-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06542939. Inclusion in this directory is not an endorsement.